Background and Purpose: New therapeutic interventions for acute ischemic stroke are aimed at improving cerebral blood flow in the first 3 to 6 hours after symptom onset. Single-photon emissioncomputed tomography (SPECT) performed in the setting of clinical therapeutic trials may give us a better understanding of the physiological response to new forms of treatment and could impact acute management decisions.
computed tomography (SPECT) in acute stroke have been published, but there are no clear recommendations for use of this information in the decision-making process in the acute period.' 10 Only a few investigators have attempted to study patients with SPECT within the first 3 to 6 hours after symptom onset. Animal studies of acute focal ischemia indicate that the first several hours of a focal ischemic insult represent the time window available for intervention, that is, before irreversible injury has occurred.4,6"11 It follows that any information from SPECT that may assist in making therapeutic decisions should be obtained in these early hours. In addition, beyond the first 24 hours the correlation of blood flow studies with the degree of ischemic injury falls off as recanalization and reperfusion occur, often associated with hyperperfusion.12"3Very few in-vestigators have attempted to use cerebral SPECT in their evaluation of patients during therapeutic clinical trials, a setting in which this information would be particularly useful." In addition, variable methods of analysis and techniques of imaging make any synthesis of this literature difficult.
We have studied patients with SPECT within the first 6 hours of the onset of hemispheric stroke symptoms to determine (1) whether we could derive a clinically useful method for measuring SPECT abnormalities in the acute stroke setting that could be used easily and reproducibly and would be amenable for use in a multicenter trial and (2) if a classification of patients according to the type and degree of ischemic injury as defined by SPECT might be possible. In addition, clinical presentation, early clinical course, and longterm outcome were compared with both the initial study and a second study measuring change during a 24-hour period to determine (3) whether SPECT results are representative of early clinical presentation and course and (4) whether this imaging technique can predict long-term outcome. symptom onset of a carotid distribution ischemic stroke with technetium-99m-labeled hexamethylpropyleneamine oxime (99mTc-HMPAO) SPECT . Those with a history or computed tomography (CT) consistent with previous ischemic stroke were excluded. All patients were also screened for randomization into one of two ongoing clinical therapeutic trials, one with a 3-hour and the other with a 6-hour entry window. Patients received a baseline SPECT before randomization and a second SPECT 24 hours after symptom onset. Each patient received a CT scan at baseline and 1 week. If the patient experienced a clinical deterioration, CT scanning was performed at the time of clinical change to evaluate for the complications of clinically significant cerebral edema or hemorrhagic conversion of ischemic infarction. These complications were defined by the CT evidence for these entities in association with a clinical deterioration. Patients were classified as to stroke mechanism using previously defined criteria.14 The National Institutes of Health Stroke Scale (NIH SS) was performed at baseline and 24 hours after symptom onset as a measure of severity of neurological deficit acutely and to document early clinical change. '5,'6 The patients could be roughly divided into three groups according to the severity of hemispheric asymmetry on their time 0 SPECT ( Table 1 ). The first group consisted of patients with mild ischemia barely detectable (patient 1) or undetectable (patient 2) with the SPECT graded scale (ranging from 0 to 5). Both patients demonstrated a good long-term recovery (Fig  lb) .
The second group, patients 3 through 11, had sizable ischemic defects with a large number of individual ROIs affected (9 to 18 abnormal ROIs per patient) but with only a moderate degree of asymmetry in isotope uptake in each ROI as quantified by the SPECT graded scale (16 to 40) (Fig lc) . Seven of the nine patients in this group showed early clinical improvement with at least a 4-point improvement on the NIH SS, and eight of the nine had a good long-term outcome (Barthel Index greater than 60). Patient 11 was the exception with poor long-term outcome (Barthel Index of 5) following a clinical deterioration that began 24 hours after stroke onset as a result of hemorrhagic conversion of her infarction.
The third group, patients 12 through 15, had severe ischemic insults in both volume (15 to 20 abnormal ROIs per patient) and degree of isotope uptake asymmetry, with a SPECT graded scale ranging from 49 to 79 (Fig ld) . All patients in this group had poor long-term outcome. Patient 15 died at 1 week because of medical complications following deterioration in her level of consciousness as a result of cerebral edema and hemorrhage. The other three patients in this group were severely disabled at 3 months (Barthel Index ranging from 0 to 50). Patient 13 had a severe defect on his initial SPECT study but at 24 hours had developed marked hyperperfusion detectable with SPECT. (Hyperperfusion is not accounted for in the SPECT graded scale.) There was no clinical improvement with this reperfusion phenomenon. Although the numbers of ROIs affected were similar in patients from groups 2 and 3, the degree of isotope uptake asymmetry was more profound in those from group 3, possibly implicating a comparative lack of collateral blood supply (Fig   ld) .
Results of the statistical analysis are summarized in Table 2 (Fig 2) . In like manner, the 24-hour SPECT study also correlated well with the 24-hour NIH SS (P< .005) (data not shown). However, when we examined the change in SPECT graded scale over 24 hours, we found no correlation with the change occurring clinically as measured by the change in the NIH SS over 24 hours (P=.45). In fact, there were divergent changes in 7 of the 15 patients (Figs 3, 4a, and 4b) . Five patients showed an improvement in SPECT without any corresponding clinical improvement (patients 1, 8, 12, 13, and 15) (Fig 4a and 4b) . This discrepancy may be another confirmation of the short time window available for reperfusion to occur to result in improved outcome. The time window may be particularly restricted in those with limited collateral supply. Three of the 5 patients (patients 12, 13, and 15) were in the third group with severe Plot shows strong association between admission single-photon emission-computed tomography (SPECT graded scale) and the complications of massive cerebral edema and hemorrhagic conversion of infarction (t=3.51, df=13, P<.005). As in the case with the Barthel Index, there was also a threshold (...) above which all patients suffered these complications. Note that the highest SPECT graded scales correspond to the most severe SPECT defects.
The NIH SS, performed within the first few hours of symptom onset in tandem with the injection of isotope for the first scan, also correlated well with both outcome measures of Barthel Index (P<.05) and the complications of cerebral hemorrhage and edema (P<.05) (Table 2). Although an initial NIH SS greater than 18 was seen in all patients with Barthel Index less than 60 and in all patients with hemorrhagic conversion or cerebral edema, there were three patients (patients 3, 5, and 10) with good or excellent outcome despite an initial NIH SS above this level (19, 24 , and 19, respectively).
Discussion
In this study, we were able to show a strong association between the severity of an ischemic insult, defined by SPECT performed within 6 hours of symptom onset, and clinical presentation, long-term outcome, and the complications of cerebral edema and hemorrhagic conversion of ischemic stroke.
Much of the work in brain SPECT for cerebrovascular disease has focused on documenting the sensitivity of the modality (versus CT scan), with only a few studies documenting the changes seen within the first 6 hours of symptom onset. 4 patient, it is doubtful that they were the direct result of treatment within the clinical trials, specifically the thrombolytic trial for which the concern for reperfusion injury is the greatest. Only one of the patients suffering complications of cerebral edema or hemorrhagic conversion of their infarct had been entered into the thrombolytic trial. Therefore, most of the complications probably represent the natural course of the patients' strokes. The strong negative predictive capability of SPECT in this study, in spite of the confounding variable of possible treatment with a potentially efficacious therapy, only strengthens the argument that this test may be able to identify those patients unlikely to respond to reperfusion, in addition to avoiding treatment of individuals at high risk for reperfusion injury (cerebral edema and hemorrhage). However, until the therapeutic studies are unblinded, our conclusions must be considered tentative.
In our study a simple clinical measure of stroke severity, the NIH SS, also correlated well with the outcome measures of the Barthel Index and the complications of cerebral hemorrhage and edema. However, the baseline NIH SS was not as specific as SPECT in predicting poor outcome in our small sample. Furthermore, the NIH SS cannot provide the physiological data that are obtained with SPECT, which may be useful in understanding the clinical response to treatment.
The use of SPECT by other investigators in larger numbers of patients early in clinical trials of potential reperfusion therapies is imperative if the full value of these tests is to be ascertained. If our hypothesis, that the 24-hour time point is too late to determine the adequacy of reperfusion, is correct, methods for rescanning at an earlier time point may be needed to better document the time course and adequacy of reperfusion therapy. Also, rapid acquisition techniques with shorter scanning times may be required to make SPECT more valuable to the practicing clinician who will be dealing with an extremely short time window in which to obtain this information before treatment.24
Our conclusions are as follows: (1) We have shown the feasibility of performing SPECT in the emergency room within the first 6 hours of symptom onset and the methodology for a semiquantitative analysis of SPECT that could be used in multicentered clinical trials. (2) SPECT may be useful for classification of patients by the type and degree of ischemic injury. Further studies are needed to confirm our findings. (3) The change in cerebral perfusion over 24 hours as measured with the SPECT graded scale does not correlate well with clinical change as measured by the NIH SS or long-term outcome. (4) The severity of SPECT abnormalities in the first 6 hours of ischemia is highly predictive of outcome, and there appears to be a threshold effect for the hemispheric asymmetry in isotope uptake, above which all patients have a poor long-term outcome. Further studies are needed to confirm our findings. (5) A threshold of asymmetry in isotope uptake may exist in acutely performed SPECT, above which patients have a high likelihood of developing the complications of edema or hemorrhage, a setting in which reperfusion therapy may yield catastrophic consequences. Further studies are needed to confirm our findings.
